Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Niewöhner

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Genomics & Proteomics|July 3, 2015
The Blood-Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological DiseasesUlrich H Weidle, Jens Niewöhner, Georg Tiefenthaler
Cell Motility and the Cytoskeleton|September 5, 2002
A talin fragment as an actin trap visualizing actin flow in chemotaxis, endocytosis, and cytokinesisIgor Weber, Jens Niewöhner, Aiping Du, et al.
Photochemistry and Photobiology|December 30, 2004
Toward understanding the mechanism of chromophore-assisted laser inactivation--evidence for the primary photochemical stepsElke Horstkotte, Torsten Schröder, Jens Niewöhner, et al.
Proteomics|March 29, 2002
Functional proteomics using chromophore-assisted laser inactivationSusanne Rubenwolf, Jens Niewöhner, Elisabeth Meyer, et al.
Biological Chemistry|February 22, 2018
Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier modelDaniela Schmid, Annette Buntz, Thi Ngoc Hanh Phan, et al.
Mabs|June 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variantsTatjana Sela, Tamara Wirth, Annika Sommer, et al.
Nucleic Acids Research|October 30, 2025
Improved targeted delivery of antisense oligonucleotide with an antibody maskHung-En Hsia, Chiara Zanini, Claire Simonneau, et al.
Bioconjugate Chemistry|November 2, 2023
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic PropertiesTatjana Sela, Mads Mansø, Michel Siegel, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Genomics & Proteomics|July 3, 2015
The Blood-Brain Barrier Challenge for the Treatment of Brain Cancer, Secondary Brain Metastases, and Neurological DiseasesUlrich H Weidle, Jens Niewöhner, Georg Tiefenthaler
Cell Motility and the Cytoskeleton|September 5, 2002
A talin fragment as an actin trap visualizing actin flow in chemotaxis, endocytosis, and cytokinesisIgor Weber, Jens Niewöhner, Aiping Du, et al.
Photochemistry and Photobiology|December 30, 2004
Toward understanding the mechanism of chromophore-assisted laser inactivation--evidence for the primary photochemical stepsElke Horstkotte, Torsten Schröder, Jens Niewöhner, et al.
Proteomics|March 29, 2002
Functional proteomics using chromophore-assisted laser inactivationSusanne Rubenwolf, Jens Niewöhner, Elisabeth Meyer, et al.
Biological Chemistry|February 22, 2018
Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier modelDaniela Schmid, Annette Buntz, Thi Ngoc Hanh Phan, et al.
Mabs|June 22, 2026
Impact of ASO conjugation and receptor binding affinity on intracellular transport of mono- and bispecific TfR- and CD98-Brainshuttle<sup>TM</sup> variantsTatjana Sela, Tamara Wirth, Annika Sommer, et al.
Nucleic Acids Research|October 30, 2025
Improved targeted delivery of antisense oligonucleotide with an antibody maskHung-En Hsia, Chiara Zanini, Claire Simonneau, et al.
Bioconjugate Chemistry|November 2, 2023
Diligent Design Enables Antibody-ASO Conjugates with Optimal Pharmacokinetic PropertiesTatjana Sela, Mads Mansø, Michel Siegel, et al.
Pageof 1